EFFECTS OF VERAPAMIL ON TARDIVE-DYSKINESIA AND PSYCHOSIS IN SCHIZOPHRENIC-PATIENTS
- 1 January 1989
- journal article
- research article
- Vol. 50 (1) , 26-27
Abstract
Nine hospitalized schizophrenic patients with tardive dyskinesia were treated with the calcium-channel antagonist verapamil under single-blind conditions. The tardive dyskinesia and activation scores decreased, and the anxiety/depression scores increased. The changes were small but statistically significant.This publication has 3 references indexed in Scilit:
- Clinical and Biochemical Effects of Verapamil Administration to Schizophrenic PatientsArchives of General Psychiatry, 1987
- Antimanic effects of verapamilAmerican Journal of Psychiatry, 1984
- Intra-patient variability in the measurement of tardive dyskinesiaPsychopharmacology, 1982